Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Neutral (Medium term) - Aug 13, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. Has, however, received a positive signal from the moving average indicator, thus signaling a continued rise. The stock has resistance at p 8.70. Positive volume balance strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 13, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.40. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

WINS still after stock, offering 6.77 pence on the bid now. A 0.27 pence premium to the indicative bid of 6.50 pence.
6.77-7.17 pence.

WINS & EVO (house broker) on the bid, Level 2 still at 2 v 2.

MM tricks,

Level 2 for ETQ at 4 v 4 now, WINS and EVO moved to 6.25 on the bid just after one other.
They happily want sells to come, they making sure a buying frenzy doesn't start. Either an Holdings in Company announcement should be coming this week with regards to the accumalation of stock by someone or some more good news is forthcoming in due course. The size of the sells again which have been few at 50K or less. Watch out for any large buy(s) as always, and keep an eye on the offer price as that always gives a better indication with ETQ.
Naughty MM's :

Online buy price is still 7.17 pence.
Online sell price is 6.50 pence.

Still paying a premium of 0.25 pence on the bid.

100,000 Buy has just come through at 7.00 pence...

hi. Please read today's SUN on MRSA. Also notice all MM are levelled on thh b/o. Any comments Sue? Ta

Hi Xmortal, see my earlier posts today about the MM's. Level 2 is still at 4 v 4 with WINS continuing to offer a premium of 0.25 pence on the bid for stock as of last Thursday.

Thanks for the mention about The Sun articles Xmortal.

Here they are (MRSA still on the increase) :

NHS disgrace


A SUN investigation reveals that levels of the deadly MRSA superbug are actually INCREASING in many NHS hospitals.
Shockingly, the situation is worse in seven of ten hospitals we first tested eight months ago.

Our investigations prove that despite promise after promise, and the expenditure of billions, many NHS trusts are NOT beating MRSA.

Patients are terrified of going into hospital with good reason.

Nearly ten per cent of all patients catch infections in hospital. At least 5,000 of them are killed.

Many hospitals checked by The Sun still give an impression of being sloppy, chaotic and filthy.

Dont just take our word for it.

Last month Sir John Bourn, chief of the National Audit Office, said that despite being warned to improve FOUR YEARS ago, the NHS still does not have a proper grasp of the extent and cost of hospital-acquired infections.

Yet, as we report today, it IS possible to defeat MRSA.

Great Ormond Street childrens hospital has a strict system of cleaning and infection control and so far this year no child has been infected there with MRSA.

If Great Ormond Street can manage it, why cant the others?

NHS still dirty and deadly

Infection ... hospital superbug

By EMMA MORTON

LEVELS of killer superbug MRSA are rocketing in hospitals, a shock probe by The Sun reveals today.

Seven of ten we tested have worse figures than eight months ago, despite a vowed blitz.

Our team found dangerously high counts in places such as entrances to intensive care and even bone marrow treatment units.

Doors, lifts, pay phones and stair rails were also covered with the bug in still grimy and badly cleaned areas. The chilling findings were made as we went back to major hospitals tested in December.

Newcastle General, the worst infected last year, STILL had the highest level even though it had gone down.

And Chelsea and Westminster where Cherie Blair had son Leo recorded a seven-times increase.

Swab tests were taken at nine points in each hospital and samples analysed in a lab after two days incubation to get an average figure.

Microbiologist Chris Malyszewicz, who tested results from both probes, said he was horrified at the rises.

He measured the number of Colony Forming Units per square cm with 0.1 being low and 0.5 high.

But Chris, whose detailed findings are revealed on this page, added: You can become ill from any amount. The figures will embarrass Health Secretary John Reid who vowed a crackdown on ward bugs that kill 5,000 a year.

They follow a Sun probe last week when a reporter doing a cleaning job was told to re-use cloths that had wiped loos.

Recorded MRSA deaths are now 800 a year but the real figure is thought to be much higher. Survivors can end up having limbs amputated.

Patients groups reacted with anger at our findings. Peter Walsh, of charity Action Against Medical Accidents, said: They are shocking. Tony Field, of MRSA Support, said: We are not surprised.

The trades reported at 6.25 pence for 135,471 pence looks like a rollover. No change on Level 2 still at 4 v 4.

Those trades were a rollover for sure. They were simultaneously put through together on 2 August 2004. Exactly ten trading days ago when a lot of heavy buying occurred on that day due to mention in the daily mail on that weekend with regards to the Buy note from Evolution Beeson Gregory. Not surprising then other T10s expire today and MMs have hence widened the spread and lowered the bid to 6.25 pence even though they are still offering 6.50 pence.

The next batch of T10s expire on this coming thursday from Friday 6 August 2004 when the NHS presentation RNS was announced. As always keep an eye on the offer price, that says it all if you don't have access to level 2.

WINS could not get much stock back even with T10s exiting and hence moved to 7 pence on the offer. Remember it has been WINS chasing stock and filling the large buy orders over the last week.

Level 2 now is very positive at 3 v 1 with just WINS on the offer.

The tricks by WINS is so evident on Level 2, continued to pay a premium on the bid for the last three days and they still could not pick up any stock and hence now moved down on the offer and see if that panics some into selling.

for goodness sake!! Can`t you see the dying momentum and the similarities to january 2004

No Snip, I can't. You are not looking at the newsflow and whats happening on Level 2. This is a better stock that the one you tried to ramp up on Friday which was NMT. You're producing a different chart all the time.

It still did not happen for them, just a handful of sells. Most of the T10 holders may have decided to keep hold of their holdings with the pipeline of good news to come.
Not even one sell since WINS moved onto the offer of 7.00 pence at 4.17pm. That must be embarassing for them.

With level 2 closing at 3 v 1 at 6.25-7.00 pence which is the best it can get we should get a blue day tomorrow now. US markets look good today as well.

heh?? I know nothing about nmt and have never discussed nmt.

As you know I do NOT ramp. I say it as it is

Aplogies it was Snip24, got no idea who that is.

You're still concentrating too much on the charts, its your choice.

With the NHS presentations on 1 Sept 2004 I'm not bailing out, and with the amount of large buys I've seen compared to the minisucle sells and the action on Level 2 I think much more gains will be forthcoming in the next 4-6 weeks.

Hi Sue i have not bought her yet but i read your posts, could you explain a little more about watching the offer if you dont have level 2?

Hi John, the offer price gives you a better indication (see my earlier post). For example, today the T10 holders had their settlement due which the market makers are aware. Hence the market makers knew they would have to sell out and hence lowered the bid price and made the spread at 1 pence which is the maximum. Now they did not bring the offer price down right until ten minutes before close when they tried to panic some into selling and even they were still offering a premium of 0.25 pence on the bid all day for the third trading in a row even though they could have done without that. WINTERFLOODS who is one of the market makers is definetely upto something here, they have been paying a premium on the bid, the premium was 0.27 pence first thing this morning, and they have been filling the large buy orders that came through last week (look at the trades over the last ten trading days). It failed, and L2 closed at its strongest at 3 v 1 so expect a blue day tomorrow. They still not get any sells and I think most of them decided to keep hold of their stock by making the purchase.

Look at the trades on 2 August 2004 and 6 August 2004 for clues to my other posts. It would be a good idea for you to read through my post from when I first bought in at 4.95 pence and how things have developed since then. It will give you a further insight into the ETQ as well.

The chart may not be very pretty yet but then again it was worse when I first got in at 4.95 pence. Snip posted an investtech post about a falling trend at the time but now I can post an Investtech post about a rising trend.

The market makers always play about with the bid price, they are reluctant to bring the offer price down as this stock is on many radars an on each time the buys come in again when they do decide to that.

If you want to buy these with no risk at all then wait for the next news release.